Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rituximab in Patients With ST-elevation Myocardial Infarction — Stella

Home/ST Elevated Myocardial Infarction/Rituximab in Patients With ST-elevation Myocardial Infarction

View on ClinicalTrials.gov

Recruiting

Back to ST Elevated Myocardial Infarction trials

Rituximab in Patients With ST-elevation Myocardial Infarction

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

France

Cardiology department, Hôpital Bichat, AP-HP, Paris

Key details

Phase

Safety & dosing

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~372 participants

Started

June 2022

Primary completion

October 2026

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.